BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

By Gnaneshwar Rajan and Sriparna Roy Jan 30 (Reuters) - Regeneron Pharmaceuticals' executives voiced confidence in its ...

Adult obesity in the United States has gone up over the past 30 years. Here's a look at why.

The novel metabolic predictor emphasizes central adiposity, while integrating metabolites and other measures of metabolic ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

JD Vance insisted he's not Donald Trump's 'fat' friend who the president was talking about at a cabinet meeting.

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Weight loss jabs will be given to up to 300 people in Guernsey during a two-year trial which could pave the way to them being ...

America’s obesity problem is tipping the scales. A new study found that the share of US adults living with obesity has more ...

Researchers predict the obesity rate among U.S. adults will rise to 47% of the population by 2035. Experts say this trend can ...

Intermittent fasting and calorie deficits can both be used for weight management and fat loss—in most cases, the most ...

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...